The seniors housing industry has been particularly hard-hit since 2020; here are ideas on rewarding and retaining difference-making talent.

Unlike an earlier proposal, the current Act does not include legislation directly impacting executive compensation, although there may be some derivative impact.

When considering staffing reductions, a fair and empathetic compensation program is imperative in the tight-knit biotech and pharma industries.

Leadership transition is an ongoing process. Here are four guiding points for boards and CEOs that former Pearl Meyer Chairman David Swinford suggested considering.

Data and context on the relationship between historically premium pay for the audit committee chair compared to other committee chairs.

For biotech, the retention value of options is currently in jeopardy. Here are several key points to weigh if your company is considering strong action.

Here are four key strategies real estate firms are using to address the Great Resignation and build a stronger, more cohesive, and inclusive culture.

Responses from 337 companies indicate base salary increases are higher than normal and many are planning mid-year raises.

A changing talent landscape and numerous external influences may require the board to look closer at workforce pay.

Insights and proven approaches from a roundtable discussion with banking executives and Pearl Meyer.

Diversity, equity, and inclusion goals aren’t just for the organization; boards can also benefit from DE&I initiatives.